Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new england journal of medicine
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
What
drug
2
×
new
2
×
advantages
approved
bar
bio
brings
cancer
deeper
dna
expect
fda
fingerprint
gamble
genetic
going
market
matter
medco’s
medicine
mover
nd
oks
patients
payers
physicians
plan
pricing
roundup
second
sets
targets
time
tissues
tumor's
type
ubiome
undone
vertex’s
world
Language
unset
Current search:
roche
×
drug
×
" raleigh-durham blog main "
×
new
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues